MAIA Biotechnology (MAIA)
Developing ateganosine, a telomere-targeting treatment for later-line lung cancer.
$1.37
Pre-market−0.01 (−1.08%)
At close$1.39(+6.54%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions37 holders · as of Jun 30, 2026 | 22.24% | 13.52M shares | |
| Insiders1 holder · as of Sep 1, 2026 | 1.21% | 735.7K shares | |
| Otherremainder | 76.55% | 46.57M shares |
60.83M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Institutions13F, as of Jun 30, 2026
37 holders · 13.52M shares · 14 new positions · 23 increased · 3 reduced · 9 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Solas Capital Management, LLC | 3.03M | 4.98% | −1.27M | Aug 14, 2026 |
| Alyeska Investment Group, L.P. | 2.50M | 4.11% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 2.41M | 3.97% | +339.2K | Aug 13, 2026 |
| 683 Capital Management, LLC | 1.07M | 1.75% | 0 | Aug 14, 2026 |
| Centric Wealth Management | 796.7K | 1.31% | 0 | Aug 6, 2026 |
| Cable Car Capital LLC | 514.6K | 0.85% | −133.9K | Aug 14, 2026 |
| Geode Capital Management, LLC | 504.4K | 0.83% | +143.9K | Aug 12, 2026 |
| Bleichroeder LP | 500.0K | 0.82% | 0 | Aug 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FGMK Business Holdings, LLC | 9.99% | 2.89M | 13G | Mar 3, 2025 ↗ |
| Vlad Vitoc | 9.66% | 3.85M | 13D | Dec 4, 2025 ↗ |
| Solas Capital Management, LLC | 7.10% | 4.30M | 13G | May 15, 2026 ↗ |
| Louie Ngar Yee | 6.50% | 1.59M | 13D | Oct 25, 2024 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 28, 2026 | Ramiro Guerrerodirector | Purchase | 46,620 | $1.35 | 735,701 |
| Aug 27, 2026 | Ramiro Guerrerodirector | Purchase | 78,239 | $1.39 | 689,081 |
| Aug 26, 2026 | Ramiro Guerrerodirector | Purchase | 8,931 | $1.39 | 610,842 |
| Aug 24, 2026 | Ramiro Guerrerodirector | Purchase | 1,794 | $1.33 | 601,911 |
| Aug 20, 2026 | Ramiro Guerrerodirector | Purchase | 11,899 | $1.37 | 600,117 |
CongressHouse and Senate disclosures
Not reported.